In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Regeneron announces Velocigene agreement
Sanofi-aventis and Regeneron Pharmaceuticals reaffirm development commitment
Sanofi-aventis and Regeron Pharmaceuticals expand their VEGF Trap oncology collaboration to Japan
Sanofi-aventis to Acquire Merck's Interest in Merial
Sanofi-aventis to Acquire Merck's Interest in Merial
Sanofi-aventis to Acquire Merck's Interest in Merial
Sanofi-aventis to collaborate with Combinature on combinatorial biosynthesis
Cerep signs a license agreement with sanofi-aventis and receives the first milestone payment/